Senate Judiciary Committee Advances Legislation to Reduce Drug Prices, Rein in Pharma Industry Practices

“I agree with the general proposition across these four bills… But I also am concerned that we continue to protect the patent system itself…. Overly aggressive use of the tools created in this legislation could sweep up good actors as well as bad actors could have unintended negative consequences,” – Senator Chris Coons Earlier today, the Senate Judiciary Committee held an Executive Business Meeting in which the Committee discussed and favorably reported four bills aimed at reducing prescription drug prices for consumers and curbing perceived abuses of the patent system by brand pharmaceutical companies. The bills would do so by increasing …

Read the source article at IPWatchdog.com
2021-07-30 19:25:56